The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Estimation of the worldwide seroprevalence of cytomegalovirus: A systematic review and meta‐analysis
Open accessAbstract
Summary: Cytomegalovirus (CMV) infection does not usually produce symptoms when it causes primary infection, reinfection, or reactivation because these three types of infection are all controlled by the normal immune system. However, CMV becomes an important pathogen in individuals whose immune system is immature or compromised, such as the unborn child. Several vaccines against CMV are currently in clinical trials that aim to induce immunity in seronegative individuals and/or to boost the immunity of those with prior natural infection (seropositives). To facilitate estimation of the burden of disease and the need for vaccines that induce de novo immune responses or that boost pre‐existing immunity to CMV, we conducted a systematic survey of the published literature to describe the global seroprevalence of CMV IgG antibodies. We estimated a global CMV seroprevalence of 83% (95%UI: 78‐88) in the general population, 86% (95%UI: 83‐89) in women of childbearing age, and 86% (95%UI: 82‐89) in donors of blood or organs. For each of these three groups, the highest seroprevalence was seen in the World Health Organisation (WHO) Eastern Mediterranean region 90% (95%UI: 85‐94) and the lowest in WHO European region 66% (95%UI: 56‐74). These estimates of the worldwide CMV distribution will help develop national and regional burden of disease models and inform future vaccine development efforts.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & the PRISMA Group* (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-4-200908180-00135 · Cited by 37,554
brms : An R Package for Bayesian Multilevel Models Using Stan
Bürkner, P.-C. (2017) · Journal of Statistical Software · doi:10.18637/jss.v080.i01 · Cited by 9,476
Review and meta‐analysis of the epidemiology of congenital cytomegalovirus (CMV) infection
Kenneson, A., & Cannon, M. J. (2007) · Reviews in Medical Virology · doi:10.1002/rmv.535 · Cited by 1,720
Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection
Cannon, M. J., Schmid, D. S., & Hyde, T. B. (2010) · Reviews in Medical Virology · doi:10.1002/rmv.655 · Cited by 1,495
Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation
Marty, F. M., Ljungman, P., Chemaly, R. F., Maertens, J., Dadwal, S. S., Duarte, R. F., Haider, S., Ullmann, A. J., Katayama, Y., Brown, J., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1706640 · Cited by 1,238
Vaccine Prevention of Maternal Cytomegalovirus Infection
Pass, R. F., Zhang, C., Evans, A., Simpson, T., Andrews, W., Huang, M.-L., Corey, L., Hill, J., Davis, E., Flanigan, C., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0804749 · Cited by 713
Bate, S. L., Dollard, S. C., & Cannon, M. J. (2010) · Clinical Infectious Diseases · doi:10.1086/652438 · Cited by 681
The pathogenesis of human cytomegalovirus
Griffiths, P., Baraniak, I., & Reeves, M. (2015) · The Journal of Pathology · doi:10.1002/path.4437 · Cited by 592
Self-citationEmery, V. C., Sabin, C. A., Cope, A. V., Gor, D., Hassan-Walker, A. F., & Griffiths, P. D. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02350-3 · Cited by 545
Self-citationVaccines for the 21st Century: A Tool for Decisionmaking
Stratton, K. R., Durch, J. S., & Lawrence, R. S. (2013) · Cited by 440
Simanek, A. M., Dowd, J. B., Pawelec, G., Melzer, D., Dutta, A., & Aiello, A. E. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016103 · Cited by 396
Modlin, J. F., Arvin, A. M., Fast, P., Myers, M., Plotkin, S., & Rabinovich, R. (2004) · Clinical Infectious Diseases · doi:10.1086/421999 · Cited by 331
Cannon, M. J., Hyde, T. B., & Schmid, D. S. (2011) · Reviews in Medical Virology · doi:10.1002/rmv.695 · Cited by 316
A prospective study of primary cytomegalovirus infection during pregnancy: final report
GRIFFITHS, P. D., & BABOONIAN, C. (1984) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1984.tb05915.x · Cited by 242
Self-citationThe Indirect Effects of Cytomegalovirus Infection on the Outcome of Organ Transplantation
Rubin, R. H. (1989) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1989.03420240121038 · Cited by 240
Kharfan-Dabaja, M. A., Boeckh, M., Wilck, M. B., Langston, A. A., Chu, A. H., Wloch, M. K., Guterwill, D. F., Smith, L. R., Rolland, A. P., & Kenney, R. T. (2012) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70344-9 · Cited by 232
TOWNE-VACCINE-INDUCED PREVENTION OF CYTOMEGALOVIRUS DISEASE AFTER RENAL TRANSPLANTS
Plotkin, S., Friedman, H., Fleisher, G., Dafoe, D., Grossman, R., Lynn Smiley, M., Starr, S., Wlodaver, C., Friedman, A., & Barker, C. (1984) · The Lancet · doi:10.1016/s0140-6736(84)90930-9 · Cited by 221
de Vries, J. J. C., van Zwet, E. W., Dekker, F. W., Kroes, A. C. M., Verkerk, P. H., & Vossen, A. C. T. M. (2013) · Reviews in Medical Virology · doi:10.1002/rmv.1744 · Cited by 195
ENDEMIC EPILEPSY IN AN ISOLATED REGION OF LIBERIA
Goudsmit, J., & Van Der Waals, F. (1983) · The Lancet · doi:10.1016/s0140-6736(83)92215-8 · Cited by 170
Wimperis, J. Z., Prentice, H. G., Karayiannis, P., Brenner, M. K., Reittie, J. E., Griffiths, P. D., & Hoffbrand, A. V. (1986) · The Lancet · doi:10.1016/s0140-6736(86)92315-9 · Cited by 152
Self-citationGkrania‐Klotsas, E., Langenberg, C., Sharp, S. J., Luben, R., Khaw, K., & Wareham, N. J. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit083 · Cited by 128
Cytomegalovirus Vaccines: Current Status and Future Prospects
Anderholm, K. M., Bierle, C. J., & Schleiss, M. R. (2016) · Drugs · doi:10.1007/s40265-016-0653-5 · Cited by 117
Sabbaj, S., Pass, R. F., Pichon, S., et al. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir138 · Cited by 111
Pembrey, L., Raynor, P., Griffiths, P., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081881 · Cited by 101
Self-citationGuerra, B., Simonazzi, G., Banfi, A., et al. (2007) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2006.08.039 · Cited by 83
Lilleri, D., & Gerna, G. (2016) · Reviews in Medical Virology · doi:10.1002/rmv.1921 · Cited by 52
Cited by
Lee, K. H., Kwon, D. E., Do Han, K., La, Y., & Han, S. H. (2020) · BMC Neurology · doi:10.1186/s12883-020-01776-3 · Cited by 35
Spaceflight virology: what do we know about viral threats in the spaceflight environment?
Pavletić, B., Runzheimer, K., Siems, K., Koch, S., Cortesão, M., Ramos-Nascimento, A., & Moeller, R. (2022) · Astrobiology · doi:10.1089/ast.2021.0009 · Cited by 30
The GATE glycoprotein complex enhances human cytomegalovirus entry in endothelial cells
Norris, M. J., Henderson, L. A., Siddiquey, M. N. A., Yin, J., Yoo, K., Brunel, S., Mor, M., Saphire, E. O., Benedict, C. A., & Kamil, J. P. (2025) · Nature Microbiology · doi:10.1038/s41564-025-02025-4 · Cited by 14
Metadata
- Authors
- Zuhair, M., Smit, G. S. A., Wallis, G., Jabbar, F., Smith, C., Devleesschauwer, B., & Griffiths, P.
- Venue
- Reviews in Medical Virology
- Publisher
- Wiley
- Published
- 2019-01-31
- Volume
- 29
- Issue
- 3
- Pages
- e2034-e2034
- ISSN
- 1052-9276 (ISSN-L)
- 1099-1654
- OpenAlex
- W2911460858
- Cited by
- 889
- References
- 26
- FWCI
- 17.24
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
